Cutler Group LP Omeros Corp Transaction History

Cutler Group LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	BUY	$5.67 - $8.54 $82,776 - $124,675	14,599 Added 625.49%	16,933 $108,000
Q3 2021 Oct 26, 2021	BUY	$13.4 - $16.3 $31,275 - $38,044	2,334 New	2,334 $32,000
Q1 2021 Apr 26, 2021	SELL	$14.52 - $23.53 $21,794 - $35,318	-1,501 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$10.14 - $15.19 $12,097 - $18,121	-1,193 Reduced 44.28%	1,501 $21,000
Q3 2020 Oct 27, 2020	BUY	$9.57 - $21.32 $20,996 - $46,776	2,194 Added 438.8%	2,694 $27,000
Q2 2020 Jul 22, 2020	BUY	$12.21 - $16.99 $6,105 - $8,495	500 New	500 $7,000
Q1 2019 May 10, 2019	SELL	$11.65 - $17.72 $9,774 - $14,867	-839 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$17.73 - $26.69 $81,558 - $122,774	-4,600 Reduced 84.57%	839 $20,000
Q2 2018 Aug 10, 2018	SELL	$10.79 - $24.44 $5,697 - $12,904	-528 Reduced 8.85%	5,439 $98,000
Q1 2018 May 11, 2018	BUY	$9.0 - $20.16 $30,276 - $67,818	3,364 Added 129.24%	5,967 $66,000
Q4 2017 Jan 17, 2018	BUY	$13.26 - $22.86 $6,378 - $10,995	481 Added 22.67%	2,603 $50,000
Q3 2017 Oct 17, 2017	BUY	$19.76 - $24.9 $41,930 - $52,837	2,122	2,122 $45,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.